[1]
Polymenidou M,Cleveland DW, The seeds of neurodegeneration: prion-like spreading in ALS. Cell. 2011 Oct 28 [PubMed PMID: 22036560]
[2]
Philips T,Robberecht W, Neuroinflammation in amyotrophic lateral sclerosis: role of glial activation in motor neuron disease. The Lancet. Neurology. 2011 Mar [PubMed PMID: 21349440]
[3]
Byrne S,Elamin M,Bede P,Shatunov A,Walsh C,Corr B,Heverin M,Jordan N,Kenna K,Lynch C,McLaughlin RL,Iyer PM,O'Brien C,Phukan J,Wynne B,Bokde AL,Bradley DG,Pender N,Al-Chalabi A,Hardiman O, Cognitive and clinical characteristics of patients with amyotrophic lateral sclerosis carrying a C9orf72 repeat expansion: a population-based cohort study. The Lancet. Neurology. 2012 Mar [PubMed PMID: 22305801]
[4]
Zou ZY,Zhou ZR,Che CH,Liu CY,He RL,Huang HP, Genetic epidemiology of amyotrophic lateral sclerosis: a systematic review and meta-analysis. Journal of neurology, neurosurgery, and psychiatry. 2017 Jul; [PubMed PMID: 28057713]
[5]
Turner MR,Swash M, The expanding syndrome of amyotrophic lateral sclerosis: a clinical and molecular odyssey. Journal of neurology, neurosurgery, and psychiatry. 2015 Jun; [PubMed PMID: 25644224]
[6]
Mehta P,Kaye W,Raymond J,Punjani R,Larson T,Cohen J,Muravov O,Horton K, Prevalence of Amyotrophic Lateral Sclerosis - United States, 2015. MMWR. Morbidity and mortality weekly report. 2018 Nov 23 [PubMed PMID: 30462626]
[7]
Jordan H,Rechtman L,Wagner L,Kaye WE, Amyotrophic lateral sclerosis surveillance in Baltimore and Philadelphia. Muscle & nerve. 2015 Jun [PubMed PMID: 25298019]
[8]
Jordan H,Fagliano J,Rechtman L,Lefkowitz D,Kaye W, Population-based surveillance of amyotrophic lateral sclerosis in New Jersey, 2009-2011. Neuroepidemiology. 2014 [PubMed PMID: 25323440]
[9]
Worms PM, The epidemiology of motor neuron diseases: a review of recent studies. Journal of the neurological sciences. 2001 Oct 15; [PubMed PMID: 11676986]
[10]
Cronin S,Hardiman O,Traynor BJ, Ethnic variation in the incidence of ALS: a systematic review. Neurology. 2007 Mar 27; [PubMed PMID: 17389304]
[11]
Chiò A,Logroscino G,Traynor BJ,Collins J,Simeone JC,Goldstein LA,White LA, Global epidemiology of amyotrophic lateral sclerosis: a systematic review of the published literature. Neuroepidemiology. 2013 [PubMed PMID: 23860588]
[13]
Saberi S,Stauffer JE,Schulte DJ,Ravits J, Neuropathology of Amyotrophic Lateral Sclerosis and Its Variants. Neurologic clinics. 2015 Nov; [PubMed PMID: 26515626]
[14]
Piao YS,Wakabayashi K,Kakita A,Yamada M,Hayashi S,Morita T,Ikuta F,Oyanagi K,Takahashi H, Neuropathology with clinical correlations of sporadic amyotrophic lateral sclerosis: 102 autopsy cases examined between 1962 and 2000. Brain pathology (Zurich, Switzerland). 2003 Jan; [PubMed PMID: 12580541]
[15]
Geser F,Martinez-Lage M,Robinson J,Uryu K,Neumann M,Brandmeir NJ,Xie SX,Kwong LK,Elman L,McCluskey L,Clark CM,Malunda J,Miller BL,Zimmerman EA,Qian J,Van Deerlin V,Grossman M,Lee VM,Trojanowski JQ, Clinical and pathological continuum of multisystem TDP-43 proteinopathies. Archives of neurology. 2009 Feb; [PubMed PMID: 19204154]
[16]
Zarei S,Carr K,Reiley L,Diaz K,Guerra O,Altamirano PF,Pagani W,Lodin D,Orozco G,Chinea A, A comprehensive review of amyotrophic lateral sclerosis. Surgical neurology international. 2015; [PubMed PMID: 26629397]
[17]
Couratier P,Truong C,Khalil M,Devière F,Vallat JM, Clinical features of flail arm syndrome. Muscle & nerve. 2000 Apr [PubMed PMID: 10716778]
[18]
Wijesekera LC,Mathers S,Talman P,Galtrey C,Parkinson MH,Ganesalingam J,Willey E,Ampong MA,Ellis CM,Shaw CE,Al-Chalabi A,Leigh PN, Natural history and clinical features of the flail arm and flail leg ALS variants. Neurology. 2009 Mar 24 [PubMed PMID: 19307543]
[19]
Rowland LP, Progressive muscular atrophy and other lower motor neuron syndromes of adults. Muscle & nerve. 2010 Feb [PubMed PMID: 20082312]
[20]
Gordon PH,Cheng B,Katz IB,Pinto M,Hays AP,Mitsumoto H,Rowland LP, The natural history of primary lateral sclerosis. Neurology. 2006 Mar 14 [PubMed PMID: 16534101]
[22]
McCluskey LF,Elman LB,Martinez-Lage M,Van Deerlin V,Yuan W,Clay D,Siderowf A,Trojanowski JQ, Amyotrophic lateral sclerosis-plus syndrome with TAR DNA-binding protein-43 pathology. Archives of neurology. 2009 Jan [PubMed PMID: 19139310]
[23]
Brooks BR,Miller RG,Swash M,Munsat TL, El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotrophic lateral sclerosis and other motor neuron disorders : official publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases. 2000 Dec; [PubMed PMID: 11464847]
[24]
Krivickas LS, Amyotrophic lateral sclerosis and other motor neuron diseases. Physical medicine and rehabilitation clinics of North America. 2003 May [PubMed PMID: 12795519]
[25]
Costa J,Swash M,de Carvalho M, Awaji criteria for the diagnosis of amyotrophic lateral sclerosis:a systematic review. Archives of neurology. 2012 Nov [PubMed PMID: 22892641]
[26]
Gooch CL,Shefner JM, ALS surrogate markers. MUNE. Amyotrophic lateral sclerosis and other motor neuron disorders : official publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases. 2004 Sep [PubMed PMID: 15512887]
[27]
Kwan JY,Jeong SY,Van Gelderen P,Deng HX,Quezado MM,Danielian LE,Butman JA,Chen L,Bayat E,Russell J,Siddique T,Duyn JH,Rouault TA,Floeter MK, Iron accumulation in deep cortical layers accounts for MRI signal abnormalities in ALS: correlating 7 tesla MRI and pathology. PloS one. 2012 [PubMed PMID: 22529995]
[28]
Chakraborty S,Gupta A,Nguyen T,Bourque P, The "Motor Band Sign:" Susceptibility-Weighted Imaging in Amyotrophic Lateral Sclerosis. The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques. 2015 Jul [PubMed PMID: 25971894]
[29]
Wang S,Melhem ER,Poptani H,Woo JH, Neuroimaging in amyotrophic lateral sclerosis. Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics. 2011 Jan [PubMed PMID: 21274686]
[30]
Verma G,Woo JH,Chawla S,Wang S,Sheriff S,Elman LB,McCluskey LF,Grossman M,Melhem ER,Maudsley AA,Poptani H, Whole-brain analysis of amyotrophic lateral sclerosis by using echo-planar spectroscopic imaging. Radiology. 2013 Jun [PubMed PMID: 23360740]
[31]
Govind V,Sharma KR,Maudsley AA,Arheart KL,Saigal G,Sheriff S, Comprehensive evaluation of corticospinal tract metabolites in amyotrophic lateral sclerosis using whole-brain 1H MR spectroscopy. PloS one. 2012 [PubMed PMID: 22539984]
[32]
Miller RG,Jackson CE,Kasarskis EJ,England JD,Forshew D,Johnston W,Kalra S,Katz JS,Mitsumoto H,Rosenfeld J,Shoesmith C,Strong MJ,Woolley SC,Quality Standards Subcommittee of the American Academy of Neurology., Practice parameter update: the care of the patient with amyotrophic lateral sclerosis: multidisciplinary care, symptom management, and cognitive/behavioral impairment (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2009 Oct 13 [PubMed PMID: 19822873]
[33]
Borasio GD,Voltz R,Miller RG, Palliative care in amyotrophic lateral sclerosis. Neurologic clinics. 2001 Nov [PubMed PMID: 11854102]
[34]
Rabinstein AA,Wijdicks EF, Warning signs of imminent respiratory failure in neurological patients. Seminars in neurology. 2003 Mar [PubMed PMID: 12870111]
[35]
Kasarskis EJ,Mendiondo MS,Matthews DE,Mitsumoto H,Tandan R,Simmons Z,Bromberg MB,Kryscio RJ, Estimating daily energy expenditure in individuals with amyotrophic lateral sclerosis. The American journal of clinical nutrition. 2014 Apr [PubMed PMID: 24522445]
[36]
Miller RG,Jackson CE,Kasarskis EJ,England JD,Forshew D,Johnston W,Kalra S,Katz JS,Mitsumoto H,Rosenfeld J,Shoesmith C,Strong MJ,Woolley SC,Quality Standards Subcommittee of the American Academy of Neurology., Practice parameter update: the care of the patient with amyotrophic lateral sclerosis: drug, nutritional, and respiratory therapies (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2009 Oct 13 [PubMed PMID: 19822872]
[37]
Körner S,Sieniawski M,Kollewe K,Rath KJ,Krampfl K,Zapf A,Dengler R,Petri S, Speech therapy and communication device: impact on quality of life and mood in patients with amyotrophic lateral sclerosis. Amyotrophic lateral sclerosis & frontotemporal degeneration. 2013 Jan [PubMed PMID: 22871079]
[38]
Weiss MD,Macklin EA,Simmons Z,Knox AS,Greenblatt DJ,Atassi N,Graves M,Parziale N,Salameh JS,Quinn C,Brown RH Jr,Distad JB,Trivedi J,Shefner JM,Barohn RJ,Pestronk A,Swenson A,Cudkowicz ME, A randomized trial of mexiletine in ALS: Safety and effects on muscle cramps and progression. Neurology. 2016 Apr 19; [PubMed PMID: 26911633]
[39]
Oskarsson B,Moore D,Mozaffar T,Ravits J,Wiedau-Pazos M,Parziale N,Joyce NC,Mandeville R,Goyal N,Cudkowicz ME,Weiss M,Miller RG,McDonald CM, Mexiletine for muscle cramps in amyotrophic lateral sclerosis: A randomized, double-blind crossover trial. Muscle & nerve. 2018 Mar 6 [PubMed PMID: 29510461]
[40]
Bedlack RS,Pastula DM,Hawes J,Heydt D, Open-label pilot trial of levetiracetam for cramps and spasticity in patients with motor neuron disease. Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases. 2009 Aug [PubMed PMID: 18821142]
[41]
Stone CA,O'Leary N, Systematic review of the effectiveness of botulinum toxin or radiotherapy for sialorrhea in patients with amyotrophic lateral sclerosis. Journal of pain and symptom management. 2009 Feb [PubMed PMID: 18676117]
[42]
Brooks BR,Thisted RA,Appel SH,Bradley WG,Olney RK,Berg JE,Pope LE,Smith RA,AVP-923 ALS Study Group., Treatment of pseudobulbar affect in ALS with dextromethorphan/quinidine: a randomized trial. Neurology. 2004 Oct 26 [PubMed PMID: 15505150]
[43]
Safety and efficacy of edaravone in well defined patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled trial. The Lancet. Neurology. 2017 Jul; [PubMed PMID: 28522181]
[46]
Hardiman O,Al-Chalabi A,Chio A,Corr EM,Logroscino G,Robberecht W,Shaw PJ,Simmons Z,van den Berg LH, Amyotrophic lateral sclerosis. Nature reviews. Disease primers. 2017 Oct 5; [PubMed PMID: 28980624]
[49]
Kiernan MC,Vucic S,Cheah BC,Turner MR,Eisen A,Hardiman O,Burrell JR,Zoing MC, Amyotrophic lateral sclerosis. Lancet (London, England). 2011 Mar 12; [PubMed PMID: 21296405]
[50]
Limousin N,Blasco H,Corcia P,Gordon PH,De Toffol B,Andres C,Praline J, Malnutrition at the time of diagnosis is associated with a shorter disease duration in ALS. Journal of the neurological sciences. 2010 Oct 15 [PubMed PMID: 20673675]
[51]
Westeneng HJ,Debray TPA,Visser AE,van Eijk RPA,Rooney JPK,Calvo A,Martin S,McDermott CJ,Thompson AG,Pinto S,Kobeleva X,Rosenbohm A,Stubendorff B,Sommer H,Middelkoop BM,Dekker AM,van Vugt JJFA,van Rheenen W,Vajda A,Heverin M,Kazoka M,Hollinger H,Gromicho M,Körner S,Ringer TM,Rödiger A,Gunkel A,Shaw CE,Bredenoord AL,van Es MA,Corcia P,Couratier P,Weber M,Grosskreutz J,Ludolph AC,Petri S,de Carvalho M,Van Damme P,Talbot K,Turner MR,Shaw PJ,Al-Chalabi A,Chiò A,Hardiman O,Moons KGM,Veldink JH,van den Berg LH, Prognosis for patients with amyotrophic lateral sclerosis: development and validation of a personalised prediction model. The Lancet. Neurology. 2018 May; [PubMed PMID: 29598923]
[52]
Chiò A,Bottacchi E,Buffa C,Mutani R,Mora G,PARALS., Positive effects of tertiary centres for amyotrophic lateral sclerosis on outcome and use of hospital facilities. Journal of neurology, neurosurgery, and psychiatry. 2006 Aug [PubMed PMID: 16614011]
[53]
Traynor BJ,Alexander M,Corr B,Frost E,Hardiman O, Effect of a multidisciplinary amyotrophic lateral sclerosis (ALS) clinic on ALS survival: a population based study, 1996-2000. Journal of neurology, neurosurgery, and psychiatry. 2003 Sep [PubMed PMID: 12933930]